Sponsored Symposia Programme

Please click on the below accordion to open each sponsored symposium and discover their programme.

Wednesday, 15.05.2019

13:00-14:00, room HELSINKI 1, Theramex – Sponsored Symposium

VVA/GSM: current and new advance?

Chair: Tim Hillard, United Kingdom

  • VVA/GSM – What do we know?
    Thomas Römer, Germany
  • Prasterone – A novel approach to the treatment of moderate to severe VVA/GSM
    Tim Hillard, United Kingdom
  • Questions and answers

13:00-14:00, room HELSINKI 2, Max Zeller Söhne AG – Lunch Symposium

Healthy aging in menopause: Focus on weight and metabolism

Chair: Veronika Butterweck, Switzerland

  • Impact of menopause on metabolism, body weight, and body composition
    Petra Stute, Switzerland
  • Bioenergetic switches by Cimicifuga racemosa extract Ze450 prevent oxidative dysregulation and mitochondrial damage in neurons and liver cells
    Carsten Culmsee, Germany

Thursday, 16.05.2019

09:15 – 10:15, room HELSINKI 1, Pantarhei Oncology – Sponsored Symposium

Treatment of Breast and Prostate Cancer with the Fetal Estrogen Estetrol

Chair: Tommaso Simoncini, Italy & Yvette Zimmerman, The Netherlands

  • The profile of the fetal estrogen estetrol (E4)
    Herjan Coelingh Bennink, The Netherlands
  • Treatment of advanced breast cancer with E4
    Hans Georg Lenhard, Germany 
  • Treatment of advanced prostate cancer with E4
    Frans Debruyne, The Netherlands

09:15 – 10:15, room HELSINKI 2, Shionogi- Sponsored Meet-the-Expert Symposium

Managing vulvovaginal atrophy (VVA) without hormones: changes in the tissues of the vagina and the vulvar vestibule and their impact on dyspareunia and quality of life

Chair: Santiago Palacios (Spain)

  • Welcome and Introduction
    Santiago Palacios, Spain
  • Effects of Ospemifene on the vulvar and vaginal tissue in women with VVA
    Cristina Meriggiola, Italy
  • Vulvar vestibular effects of Ospemifene: reducing the sensitivity of sensory nerve fibres
    Filippo Murina, Italy
  • VVA in clinical practice: case studies
    Carmen Pingarron, Spain
  • Q&A with audience, summary and close
    Santiago Palacios, Spain

12:30 – 14:00, 16.05.2019, room HELSINKI 1, Mylan – Lunch Symposium

The progestin makes the difference. Role of Dydrogesterone in HRT

Chair: Nick Panay, United Kingdom

  • “Modern” hormone therapy in menopause – Are we ready to change our approach?
    Nick Panay, United Kingdom
  • Management of menopause – Women’s fears and women’s needs
    Katrin Schaudig, Germany
  • Progestogens: Basic mode of action and differences
    Christian Egarter, Austria
  • Dydrogesterone beyond HRT indications. Review of the clinical data
    Petra Stute, Switzerland

Friday, 17.05.2019

08:00 – 09:00, room HELSINKI 1, Schaper & Brümmer – Sponsored Symposium

Yes, no, maybe? Time for consensus: An update on black cohosh (Cimicifuga racemosa) for climacteric symptoms

Chair: Alfred O. Mueck, Germany & Xiangyan Ruan, China

  • Clinical efficacy and safety of isopropanolic Cimicifuga racemosa extract (iCR)
    Camil Castelo-Branco, Spain
  • Benefit-risk profile of iCR with and without St. John’s Wort in breast cancer patients
    Harald Meden, Switzerland
  • Latest insights into iCR’s mode of action
    Petra Stute, Switzerland

08:00 – 09:00, 17.05.2019, room HELSINKI 2, Mithra- Sponsored Symposium

Estetrol (E4) – The eight o’clock news you need to take back home

Chair: Ulysse Gaspard, Belgium

  • Welcome and introduction
    Ulysse Gaspard, Belgium
  • E4 is the first native estrogen with selective tissue action
    Jean-Michel Foidart, Belgium
  • The latest E4 clinical data – Are we heading towards a new generation hormonal therapy?
    Sven O. Skouby, Denmark
  • Questions and answers

12:30 – 14:00, room HELSINKI 2, DR. KADE / Besins – Lunch Symposium

HRT – Chancen nutzen, Risiken minimieren

Chair: Alfred O. Mueck, Germany & Joseph Neulen, Germany

  • HRT kann mehr als die Behandlung von Hitzewallungen
    Petra Stute, Switzerland
  • Risiken durch eine natürliche HRT erfolgreich minimieren
    May Ziller, Germany

12:30 – 13:00, EMAS ARENA, Sérélys Pharma – Sponsored Symposium

Effect of a composition of purified and specific cytoplasm extracts of pollen (PSCEP), pumpkin seed extract and vitamin E (Femaxeen®) on women with urinary incontinence: a randomized, double-blind, placebo-controlled clinical trial

Chair: Santiago Palacios, Spain

12:30-13:15, Lindau Room 3, Alma Lasers – Sponsored Workshop

Dr. Elke Heßdörfer, Urogynecologist and Alma Lasers present the “Femilift”, a unique Pixel-CO2  technology.
The theory and practice behind the treatment of GSM (vaginal dryness, SUI, Dyspareunia, etc.). My experience and results followed by Handson session with the system.

13:15 – 14:00, EMAS ARENA, Fotona – Sponsored Lunch Symposium/Workshop

Non-ablative FotonaSmooth ErYAG laser – the safe and efficacious option for GSM, SUI, POP and VRS

Chair: Marco Gambacciani, Italy

Long-term efficacy for GSM treatment and the use of laser in breast cancer survivors
Marco Gambacciani, Italy
Use of FotonaSmooth Er:YAG laser for treatment of SUI, POP and VRS
Ivan Fistonic, Croatia
Video workshop with live commentary